ArticleBMC cancer2024

Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigator-initiated trial.

Constantin Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.